Market closed
Virios Therapeutics Inc/$DWTX
Virios Therapeutics shares are trading higher after the company announced compliance with Nasdaq's equity requirement.
12 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Virios Therapeutics Inc
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Ticker
$DWTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
12
Website
DWTX Metrics
BasicAdvanced
$4M
-
-$12.52
2.01
-
Price and volume
Market cap
$4M
Beta
2.01
52-week high
$14.69
52-week low
$2.76
Average daily volume
2.1M
Financial strength
Current ratio
5.209
Quick ratio
4.675
Long term debt to equity
0.241
Total debt to equity
0.318
Interest coverage (TTM)
-132.63%
Management effectiveness
Return on assets (TTM)
-15.52%
Return on equity (TTM)
-36.28%
Valuation
Price to book
-0.57
Price to tangible book (TTM)
-0.26
Price to free cash flow (TTM)
-0.351
Growth
Earnings per share change (TTM)
77.50%
3-year earnings per share growth (CAGR)
-36.11%
DWTX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Virios Therapeutics Inc stock?
Virios Therapeutics Inc (DWTX) has a market cap of $4M as of April 16, 2025.
What is the P/E ratio for Virios Therapeutics Inc stock?
The price to earnings (P/E) ratio for Virios Therapeutics Inc (DWTX) stock is 0 as of April 16, 2025.
Does Virios Therapeutics Inc stock pay dividends?
No, Virios Therapeutics Inc (DWTX) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Virios Therapeutics Inc dividend payment date?
Virios Therapeutics Inc (DWTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Virios Therapeutics Inc?
Virios Therapeutics Inc (DWTX) has a beta rating of 2.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.